Xenetic Biosciences (XBIO) Short Interest Ratio & Short Volume → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free XBIO Stock Alerts $4.27 +0.37 (+9.49%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Xenetic Biosciences Short Interest DataCurrent Short Volume2,800 sharesPrevious Short Volume1,700 sharesChange Vs. Previous Month+64.71%Dollar Volume Sold Short$11,592.00Short Interest Ratio / Days to Cover0.5Last Record DateApril 15, 2024Outstanding Shares1,541,000 sharesFloat Size1,250,000 sharesShort Percent of Float0.22%Today's Trading Volume5,746 sharesAverage Trading Volume3,478 sharesToday's Volume Vs. Average165% Short Selling Xenetic Biosciences ? Sign up to receive the latest short interest report for Xenetic Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatXBIO Short Interest Over TimeXBIO Days to Cover Over TimeXBIO Percentage of Float Shorted Over Time Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. Xenetic Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,800 shares $11,592.00 +64.7%0.2%0.5 $4.14 3/31/20241,700 shares $6,409.00 -22.7%0.1%0.3 $3.77 3/15/20242,200 shares $9,570.00 -74.7%0.2%0.4 $4.35 2/29/20248,700 shares $36,018.00 -20.9%0.7%1.6 $4.14 2/15/202411,000 shares $39,160.00 +0.9%0.9%2.2 $3.56 1/31/202410,900 shares $40,875.00 -35.9%0.9%2.1 $3.75 Get the Latest News and Ratings for XBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xenetic Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/202417,000 shares $65,280.00 +71.7%1.4%3.6 $3.84 12/31/20239,900 shares $34,155.99 No Change0.8%2.3 $3.45 12/15/20239,900 shares $35,244.00 -10.8%0.8%2.4 $3.56 11/30/202311,100 shares $36,352.50 +7.8%0.9%1.9 $3.28 11/15/202310,300 shares $31,930.00 No Change0.8%1.3 $3.10 10/31/202310,300 shares $31,724.00 +17.1%0.8%1.2 $3.08 10/15/20238,800 shares $37,290.88 +3.5%0.7%1 $4.24 9/30/20238,500 shares $41,650.00 -48.2%0.6%0.5 $4.90 9/15/202316,400 shares $85,772.00 +127.8%1.2%1 $5.23 8/31/20237,200 shares $28,872.00 +67.4%0.6%0.4 $4.01 8/15/20234,300 shares $16,254.00 -39.4%0.3%0.2 $3.78 7/31/20237,100 shares $27,619.00 -78.3%0.5%0.2 $3.89 7/15/202332,700 shares $119,028.00 +52.8%2.5%1 $3.64 6/30/202321,400 shares $67,624.00 -18.6%1.6%0.7 $3.16 6/15/202326,300 shares $83,897.00 -15.2%2.0%1.1 $3.19 5/31/202331,000 shares $92,535.00 +3,775.0%2.4%1.3 $2.99 5/15/2023800 shares $0.00 -77.8%0.1%0 $0.00 4/30/202335,700 shares $14,994.00 -18.7%N/A1 $0.42 4/15/202343,900 shares $20,852.50 -11.7%N/A0.9 $0.48 3/31/202349,700 shares $20,178.20 +24.3%N/A0.9 $0.41 3/15/202340,000 shares $15,600.00 +58.1%N/A0.6 $0.39 2/28/202325,300 shares $13,156.00 -34.6%N/A0.4 $0.52 2/15/202338,700 shares $22,446.00 -61.2%N/A0.5 $0.58 1/31/202399,800 shares $71,885.94 +130.0%N/A1.3 $0.72 1/15/202343,400 shares $16,492.00 +126.0%N/A0.6 $0.38 12/30/202219,200 shares $5,473.92 -31.9%N/A0.3 $0.29 12/15/202228,200 shares $10,152.00 +3.3%N/A0.5 $0.36 11/30/202227,300 shares $12,012.00 +264.0%N/A0.6 $0.44 11/15/20227,500 shares $3,188.25 +1.4%N/A0.2 $0.43 10/31/20227,400 shares $3,469.86 -70.3%N/A0.2 $0.47 10/15/202224,900 shares $13,570.50 -22.9%0.7%0.5 $0.55 9/30/202232,300 shares $17,348.33 +74.6%1.0%0.7 $0.54 9/15/202218,500 shares $13,366.25 -66.4%0.6%0.4 $0.72 8/31/202255,000 shares $41,800.00 -6.8%1.6%1.2 $0.76$21,000 in profits in six weeks? (Ad)On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.Click here for details. XBIO Short Interest - Frequently Asked Questions What is Xenetic Biosciences' current short interest? Short interest is the volume of Xenetic Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 2,800 shares of XBIO short. 0.22% of Xenetic Biosciences' shares are currently sold short. Learn More on Xenetic Biosciences' current short interest. What is a good short interest percentage for Xenetic Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.22% of Xenetic Biosciences' floating shares are currently sold short. Is Xenetic Biosciences' short interest increasing or decreasing? Xenetic Biosciences saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 2,800 shares, an increase of 64.7% from the previous total of 1,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Xenetic Biosciences' float size? Xenetic Biosciences currently has issued a total of 1,540,000 shares. Some of Xenetic Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Xenetic Biosciences currently has a public float of 1,250,000 shares. How does Xenetic Biosciences' short interest compare to its competitors? 0.22% of Xenetic Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Xenetic Biosciences: Lixte Biotechnology Holdings, Inc. (4.59%), Shuttle Pharmaceuticals Holdings, Inc. (0.77%), Enveric Biosciences, Inc. (1.40%), TFF Pharmaceuticals, Inc. (2.77%), Adial Pharmaceuticals, Inc. (26.72%), Pulmatrix, Inc. (0.32%), Ainos, Inc. (2.84%), Processa Pharmaceuticals, Inc. (8.28%), Cadrenal Therapeutics, Inc. (2.04%), Kineta, Inc. (1.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Xenetic Biosciences stock? Short selling XBIO is an investing strategy that aims to generate trading profit from Xenetic Biosciences as its price is falling. XBIO shares are trading up $0.37 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Xenetic Biosciences? A short squeeze for Xenetic Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XBIO, which in turn drives the price of the stock up even further. How often is Xenetic Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XBIO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Lixte Biotechnology Short Squeeze Shuttle Pharmaceuticals Short Squeeze Enveric Biosciences Short Squeeze TFF Pharmaceuticals Short Squeeze Adial Pharmaceuticals Short Squeeze Pulmatrix Short Squeeze Ainos Short Squeeze Processa Pharmaceuticals Short Squeeze Cadrenal Therapeutics Short Squeeze Kineta Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XBIO) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith